A complete metabolic health test includes fasting glucose, fasting insulin, HbA1c, a full lipid panel (triglycerides and HDL), high-sensitivity CRP, blood pressure, and waist circumference. The standard CMP ordered at most annual physicals includes none of the insulin markers and is not designed to detect early metabolic dysfunction. Fasting insulin — the most sensitive early marker — must be specifically requested and is missing from almost every standard panel.
Your annual blood test almost certainly missed the single most important marker of metabolic disease progression. Not because your doctor made an error. Because that marker — fasting insulin — does not appear on any standard metabolic panel. Not the Comprehensive Metabolic Panel. Not the Basic Metabolic Panel. Not the lipid panel your cardiologist orders. Nowhere.
The standard metabolic panel ordered at most annual physicals was designed in the 1970s to detect acute organ failure: kidney dysfunction, liver toxicity, dangerous electrolyte swings. It was not designed to detect the slow, decade-long drift toward insulin resistance that precedes 80% of type 2 diabetes diagnoses and the majority of cardiovascular events. And yet it remains the primary tool used to assess metabolic health in clinical practice today.
The consequence is stark. Araújo et al. 2019, analysing NHANES data from 8,721 US adults, found that 88% showed at least one marker of metabolic dysfunction. Most of them had a recent "normal" blood result. Because the tests that flag problems early — fasting insulin, HbA1c, HOMA-IR — are not routinely ordered. And the tests that are ordered only catch pathology after years of silent damage.
This guide covers exactly what a proper metabolic health test looks like: which markers to request, what the numbers actually mean, and why the gap between "normal" and "optimal" is one of the most dangerous blind spots in modern preventive medicine. We cover all of this in depth across our metabolic health knowledge hub.
What Is a Metabolic Health Test?
A metabolic health test is a panel of blood and physiological markers that assess how efficiently your body processes energy — specifically glucose and fatty acids — and how sensitive your cells remain to insulin's signal. It is not a single test. It is a framework of measurements that, read together, reveal where your metabolic system sits relative to optimal function.
The clinical definition of metabolic health, as used in research, requires that five specific markers all fall within healthy ranges simultaneously:
- Fasting blood glucose below 100 mg/dL (optimal range: 70–85 mg/dL)
- Triglycerides below 150 mg/dL (optimal: below 100 mg/dL)
- HDL cholesterol above 40 mg/dL for men / 50 mg/dL for women (optimal: above 60 mg/dL)
- Blood pressure below 120/80 mmHg
- Waist circumference below 102 cm / 40 inches (men) or 88 cm / 35 inches (women)
Only 6.8% of American adults meet all five criteria simultaneously without medication. Fewer than 1 in 14. The remaining 93.2% have at least one marker out of optimal range — and most of them do not know it because their standard panel did not check for it.
A proper metabolic health test accounts for all five of those official markers and extends further: adding fasting insulin, HbA1c, and HOMA-IR to give a complete picture of where your metabolic system sits today — and where it is heading. To understand why these markers matter at a fundamental level, read our guide on what metabolic health actually means at a clinical level.
The Core Metabolic Health Biomarkers: Normal vs Optimal
Here is where the standard medical conversation fails people. Labs report reference ranges built from population averages. In a population that is 88% metabolically dysfunctional, "normal" is a low bar. The difference between normal and optimal is the difference between "not yet diagnosed" and "functioning well."
| Biomarker | "Normal" Lab Range | Optimal Range | What It Reveals |
|---|---|---|---|
| Fasting Glucose | < 100 mg/dL | 70–85 mg/dL | Glucose clearance and insulin efficiency |
| Fasting Insulin | < 25 μIU/mL | < 5 μIU/mL | Early insulin resistance — the most sensitive early signal |
| HbA1c | < 5.7% | < 5.3% | Average blood glucose over 90 days |
| Triglycerides | < 150 mg/dL | < 100 mg/dL | Dietary fat and carbohydrate metabolism |
| HDL Cholesterol | > 40 (M) / > 50 (F) mg/dL | > 60 mg/dL | Reverse cholesterol transport and vascular health |
| Blood Pressure | < 130/80 mmHg | < 120/80 mmHg | Vascular stiffness and endothelial function |
| HOMA-IR | < 2.0 | < 1.0 | Composite insulin resistance score |
| Uric Acid | < 7.0 (M) / < 6.0 (F) mg/dL | < 5.5 mg/dL | Fructose metabolism and inflammatory load |
The "normal" fasting insulin range at many labs extends to 25 μIU/mL. That threshold was set using population averages from the general population — 88% of whom are metabolically unhealthy. Using that reference range to assess whether your insulin is healthy is like using the average speed of traffic on a congested highway to define how fast cars can safely go.
What Your Standard Blood Panel Is Not Telling You
The Comprehensive Metabolic Panel (CMP) — the standard 14-test panel ordered at most annual physicals — measures electrolytes (sodium, potassium, chloride, bicarbonate), kidney markers (BUN, creatinine), liver markers (ALT, AST, ALP, bilirubin, albumin, total protein), and blood glucose. That is what it includes.
What it does not include: fasting insulin, HbA1c, triglycerides, HDL, LDL, uric acid, high-sensitivity C-reactive protein, or HOMA-IR. Every marker on that list is more useful for detecting early metabolic dysfunction than most of what the CMP does measure.
The CMP was designed to detect acute pathology. Diabetic ketoacidosis. Acute kidney injury. Liver failure from toxin exposure. It was not designed — and should not be used — to determine whether your insulin signalling system is functioning optimally. By the time your fasting glucose rises above 100 mg/dL on a CMP, you have typically been hyperinsulinaemic for five to ten years. The glucose signal is the last one to move.
A lot of people assume that a "normal" CMP means they are metabolically healthy. That assumption is only as good as the tests being run. If your doctor did not order a fasting lipid panel, fasting insulin, and HbA1c — and most do not by default — your "normal" result is telling you very little about your actual metabolic health. The standard panel was built for a different job. It is not the right tool for this one.
The key insight: Fasting glucose above 100 mg/dL is not the start of the problem. It is the end of the early warning window. Insulin resistance begins when fasting insulin is elevated but glucose is still normal — a state that can persist for a decade or more before glucose rises above the flagging threshold.
Fasting Insulin: The Test Your Doctor Doesn't Order
Fasting insulin is the single most sensitive early marker of metabolic dysfunction. It is not included in any standard blood panel by default. You have to request it by name.
Here is the mechanism. Insulin is the hormone that signals muscle, liver, and fat cells to absorb glucose from the blood. When those cells become resistant to that signal — due to chronic overexposure from a diet high in refined carbohydrates and fructose — the pancreas compensates. It produces more insulin to achieve the same signalling effect. Blood glucose stays normal. But fasting insulin climbs.
This is hyperinsulinaemia: elevated insulin with still-normal glucose. It is the earliest detectable stage of insulin resistance. And it can persist, invisibly, for years before glucose rises above 100 mg/dL. Your CMP will look normal throughout. According to the NIH NIDDK, insulin resistance can be present for years without symptoms or elevated glucose — which is precisely why fasting insulin is the critical test that the standard panel misses.
The clinically useful thresholds for fasting insulin (not the lab's population-average reference range):
Fasting Insulin Reference Ranges (Functional Medicine)
- < 5 μIU/mL — Optimal — cells highly sensitive to insulin's signal
- 5–10 μIU/mL — Acceptable — system working harder than ideal
- 10–20 μIU/mL — Borderline elevated — early hyperinsulinaemia
- > 20 μIU/mL — Clinically elevated — significant insulin resistance even if glucose is still "normal"
Once you have both fasting glucose and fasting insulin, you can calculate HOMA-IR — the most clinically validated composite score for insulin resistance that doesn't require a specialist referral:
HOMA-IR = (Fasting Glucose [mg/dL] × Fasting Insulin [μIU/mL]) ÷ 405
Example: fasting glucose 92 mg/dL × fasting insulin 14 μIU/mL ÷ 405 = HOMA-IR of 3.2. That person would receive a completely clean CMP result. Fasting glucose of 92 is comfortably "normal." But a HOMA-IR of 3.2 places them firmly in the clinically insulin resistant range. Without the fasting insulin test, that signal is invisible.
The Complete Metabolic Health Panel: What to Request
You do not need a specialist referral to order most of these tests. Direct lab services (LabCorp Direct and Quest MyQuest both offer consumer ordering) allow you to request and pay for specific panels without a GP visit. Alternatively, hand your GP this list and ask for it at your next annual physical.
| Test | In Standard CMP? | How to Get It | Why It Matters |
|---|---|---|---|
| Fasting Glucose | ✓ Yes | Included in standard CMP | Baseline energy metabolism — but a late-stage signal |
| Fasting Insulin | ✗ No | Request by name at any draw | The earliest and most sensitive signal of insulin resistance |
| HbA1c | ✗ No | Request separately (or with diabetes screening) | 90-day average glucose — more reliable than a single fasting draw |
| Full Lipid Panel | ✗ No | Request as "fasting lipid panel" | Triglycerides and HDL — core metabolic health markers |
| High-Sensitivity CRP | ✗ No | Request as "hsCRP" or "hs-CRP" | Systemic inflammation — amplifies all other metabolic risks |
| Uric Acid | ✗ No | Request separately | Fructose metabolism marker and independent cardiovascular risk factor |
| HOMA-IR | N/A — calculation | Calculate from insulin + glucose | Composite insulin resistance score — most clinically sensitive early measure |
According to the American Diabetes Association, HbA1c between 5.7% and 6.4% defines prediabetes — but optimal metabolic function sits below 5.3%. A result of 5.6% will not trigger a clinical intervention. But it means your average glucose over the past 90 days is trending in the wrong direction. That trend, caught at 5.6%, is far easier to reverse than the same trend at 6.2%.
The difference between "normal" and "optimal" is not a subtle distinction. It is the entire window in which you can reverse insulin resistance before it becomes structural disease.
Testing Metabolic Health at Home
Three at-home tools are genuinely useful. Not gimmicky wellness tech. Genuinely useful.
Glucometer — Point-in-Time Glucose
A standard blood glucose meter costs $20–40 and gives you two critical measurements: fasting glucose (first thing in the morning, before eating or drinking anything except water) and post-meal glucose (at the 1-hour and 2-hour mark after a standardised meal). Optimal post-meal glucose peak: below 140 mg/dL. Optimal return to baseline by 2 hours. If you are spiking above 160–180 mg/dL post-meal, that is worth investigating — even if your fasting glucose is normal.
Continuous Glucose Monitor (CGM) — Real-Time Metabolic Tracking
Since 2024, CGMs are available in the US without a prescription. Dexcom Stelo and Abbott Libre Rio are the two primary OTC options approved for use in non-diabetic adults. A CGM worn for 14 consecutive days gives you: fasting glucose readings every 5 minutes overnight, real-time post-meal glucose peaks, glucose variability (lower is better), and time in range — the percentage of readings between 70 and 140 mg/dL (target: above 90%). A 14-day CGM trace reveals things that no blood panel can: how your sleep quality affects fasting glucose, how different foods affect your glucose peak and recovery, and how exercise timing changes your post-meal response. Explore the full technology landscape in our health technology deep-dives.
Direct-to-Consumer Blood Testing
Services like LabCorp Direct, Quest Direct, and Function Health allow you to order fasting insulin, HbA1c, lipid panels, and hsCRP online and complete the draw at a local collection site. Fasting insulin typically costs $25–50 as a standalone test. A comprehensive metabolic panel including fasting insulin, HbA1c, and a lipid panel can be ordered for $80–150 total. No GP referral required. The draw happens at a local phlebotomy site. Results arrive digitally within 1–3 days.
I wear a CGM for two weeks every quarter. Not because I have diabetes or any clinical risk flag. Because I cannot see the glucose impact of different meal compositions, sleep disruptions, and exercise timing any other way. A 14-day CGM trace is worth more diagnostic information than 12 months of fasting glucose point-tests for understanding your real-time metabolic response. That is not a claim — that is a consequence of what CGMs actually measure versus what a static blood draw captures.
How to Interpret Your Metabolic Health Test Results Over Time
The question I always hear: "My doctor said my results look normal — do I still need to worry?"
Possibly. "Normal" on most lab reference ranges means within the statistical range of the general population — a population in which 88% have at least one sign of metabolic dysfunction. Normal is not optimal. Normal is statistical. Optimal is functional. And the two are not close.
The goal is not to be "not sick." The goal is to maintain the physiological state in which every organ system functions at peak efficiency. That requires a higher bar than "no acute pathology detected."
| Marker | Optimal | Borderline | Clinically Concerning |
|---|---|---|---|
| Fasting Glucose | 70–85 mg/dL | 86–99 mg/dL | ≥ 100 mg/dL |
| Fasting Insulin | < 5 μIU/mL | 5–10 μIU/mL | > 10 μIU/mL |
| HbA1c | < 5.3% | 5.3–5.6% | ≥ 5.7% |
| Triglycerides | < 100 mg/dL | 100–149 mg/dL | ≥ 150 mg/dL |
| HDL | > 60 mg/dL | 50–60 mg/dL | < 40 (M) / < 50 (F) mg/dL |
| HOMA-IR | < 1.0 | 1.0–1.9 | ≥ 2.0 |
Track trends, not just snapshots. A fasting glucose of 88 mg/dL is optimal. But if it was 78 mg/dL three years ago and 84 mg/dL last year, the upward trend is worth examining — even though all three values sit within normal range. Combined with rising fasting insulin, a rising-but-still-normal glucose trend is an early, actionable signal. Metabolic markers are also one of the strongest inputs into biological ageing — use our biological age calculator to estimate how your current numbers translate into physiological age.
For those who have identified metabolic dysfunction through testing and want to understand the evidence-based interventions — dietary, lifestyle, and supplementation — our metabolic health pillar covers the full landscape. For supplement-specific evidence, including the berberine compounds that have the strongest clinical support for glucose regulation, see our Thorne Metabolic Health review and complete metabolic health supplement guide. Vitamin D deficiency is also tightly linked to insulin resistance — if you have not recently assessed your levels, our vitamin D calculator can help you estimate your needs based on sun exposure, skin tone, and location.
Frequently Asked Questions
A metabolic health test is a panel of blood and physiological measurements that assess how efficiently your body processes glucose and fat, and how sensitive your cells are to insulin. It is not a single test — it includes fasting glucose, fasting insulin, HbA1c, a full lipid panel, blood pressure, and waist circumference at minimum. Most standard medical panels miss several of these markers, particularly fasting insulin, which must be specifically requested.
The most important blood tests for metabolic health are fasting glucose (optimal 70–85 mg/dL), fasting insulin (optimal under 5 μIU/mL), HbA1c (optimal under 5.3%), triglycerides (optimal under 100 mg/dL), HDL cholesterol (optimal above 60 mg/dL), and high-sensitivity CRP for systemic inflammation. HOMA-IR — calculated from fasting glucose and fasting insulin — is the most sensitive composite measure of insulin resistance available without a specialist referral.
Most labs report fasting insulin as normal up to 25 μIU/mL — but this reference range is built from population averages, and 88% of that population is metabolically unhealthy. Optimal fasting insulin, as used by metabolic medicine specialists, is under 5 μIU/mL. Values between 5 and 10 indicate the insulin system is working harder than ideal. Values above 10 μIU/mL with normal glucose indicate hyperinsulinaemia — the earliest detectable stage of insulin resistance, often years before glucose rises.
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a composite score combining fasting glucose and fasting insulin into a single measure of insulin sensitivity. The formula is: HOMA-IR = (Fasting Glucose [mg/dL] × Fasting Insulin [μIU/mL]) ÷ 405. A score below 1.0 indicates optimal insulin sensitivity. Scores between 1.0 and 1.9 are borderline. Scores at or above 2.0 indicate clinical insulin resistance — even if fasting glucose is still within the normal range.
Yes. A continuous glucose monitor (CGM), available over the counter in the US without a prescription since 2024, gives 14 days of real-time glucose data including fasting levels, post-meal peaks, and glucose variability. A glucometer measures fasting and post-meal glucose point-in-time. Direct-to-consumer blood test services allow you to order fasting insulin, HbA1c, and lipid panels online and complete the draw at a local lab site. Blood pressure and waist circumference require only a home cuff and tape measure.
For healthy adults maintaining stable habits, annual full-panel testing is sufficient. For anyone actively working to reverse insulin resistance, quarterly testing provides faster feedback — HbA1c reflects 90-day glucose averages, and fasting insulin can shift meaningfully within 6–8 weeks of dietary carbohydrate reduction. A 14-day CGM worn every 3–6 months gives the most granular real-time metabolic snapshot between blood panels.
No. The CMP includes 14 tests covering electrolytes, kidney function, liver enzymes, and blood glucose — but excludes fasting insulin, HbA1c, triglycerides, HDL, uric acid, and hsCRP. It was designed to detect acute organ failure, not the slow progression of insulin resistance. For a complete metabolic health assessment, you need fasting insulin and HbA1c ordered separately at minimum, plus a lipid panel for triglycerides and HDL cholesterol.
